A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients with Recurrent Small Cell LungCancer: Big Ten Cancer Research Consortium BTCRC-LUN17-127

Project: Research project

Project Details

Description

A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients with Recurrent Small Cell Lung Cancer: Big Ten Cancer Research Consortium BTCRC-LUN17-127
StatusActive
Effective start/end date8/30/188/30/23

Funding

  • BIG TEN CANCER RESEARCH CONSORTIUM

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.